| Name | Title | Contact Details |
|---|
San Diego FC is a Major League Soccer (MLS) expansion team set to begin play in 2025. Owned by Sir Mohamed Mansour through his family office, Man Capital, the club focuses on social impact, environmental sustainability, and youth development. It operates under the Right to Dream model, a globally recognized soccer academy system that emphasizes holistic athlete development and community engagement. The team will compete in MLS, with home games at Snapdragon Stadium. San Diego FC also features the Right to Dream Academy, which provides free education, housing, and soccer training to young athletes. This academy aims to foster athletic development, academic excellence, and personal growth, mirroring existing facilities in Ghana, Egypt, and Denmark. Additionally, the club engages in community programs that promote diversity and inclusion, targeting local residents and youth athletes from underserved communities. The ownership structure reflects a partnership between Mansour’s Man Capital and the Sycuan Tribe, blending global sports investment with local heritage.
Estiatorio Milos is a renowned restaurant group founded in 1979 by Greek restaurateur Costas Spiliadis in Montreal. It is celebrated for its authentic Greek cuisine, emphasizing high-quality, fresh ingredients. With locations in major cities like New York, Athens, Las Vegas, Miami, London, Los Cabos, and Dubai, Milos offers refined dining experiences that prioritize simplicity and the art of sharing. The restaurant specializes in Mediterranean seafood, featuring fresh fish and shellfish sourced directly from Greek fishermen. Dishes are crafted to highlight natural flavors, often using artisanal ingredients like cold-pressed Koroneiki olive oil and seasonal vegetables. Milos is known for its warm hospitality and communal dining atmosphere, making it a favorite among discerning diners and culinary enthusiasts seeking an authentic taste of Greece.
LTCG is a leading provider of business process outsourcing for the insurance industry. The nations largest insurers rely on our unparalleled expertise to help manage their complex long-term care portfolios and maximize financial performance. We also provide clients with advanced risk management insight built upon our unique and proprietary long-term care underwriting and claims databases. LTCG has more than 1.4 million long-term care policies currently under its management, representing nearly 20% of all active policies. We serve over 50 national carriers, including every one of the top 10 insurers in the long-term care market. Our experienced management team, which has worked together for years, includes some of the most recognized and respected leaders in the long-term care industry. And our information systems have been developed specifically to support the intricacies of this unique market. To learn more, visit www.ltcg.com
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
88rising (stylized as 88⬆) is an American mass media company that founded in 2015 by Sean Miyashiro describes as a "hybrid management, record label, video production and marketing company." The company has gained popularity as a musical platform and label for Asian artists such as Keith Ape, Rich Brian, Joji, NIKI, and Higher Brothers. Headquartered in New York City, the company also has offices in Los Angeles and Shanghai. Outside of its core group, the company has collaborated with other artists such as Ghostface Killah, 21 Savage, XXXTentacion, Trippie Redd, Ski Mask the Slump God, Kris Wu, Yaeji, and others.